Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05743673 · ClinicalTrials.gov registry record

SHAPE Test for Preoperative Risk Stratification

A clinical trial of Perioperative/Postoperative Complications and Aerobic Capacity, sponsored by Yale University.

Recruiting
Registry status
371
Enrollment target
1
Study location

NCT05743673: Recruiting study of Perioperative/Postoperative Complications and Aerobic Capacity, sponsored by Yale University.

NCT05743673 is a study of Perioperative/Postoperative Complications and Aerobic Capacity that is actively recruiting participants, run by Yale University. The registered enrollment target is 371 participants, above the 292-participant average among 8 other Perioperative/Postoperative Complications trials with a reported enrollment target (27% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05743673, a study of Perioperative/Postoperative Complications and Aerobic Capacity, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
371 participants
Enrollment target
1
Study location

Study Summary

Primary Objective Characterizing precise functional capacity in surgical patients is critical for risk stratification and identification of patients at high risk for perioperative complications. The primary objective for the study is to evaluate the feasibility of effective subject recruitment of an FDA-approved simplified cardiopulmonary exercise testing apparatus in adults \>60 years old prior to moderate to high-risk surgery. In addition, by development of a validation cohort of older adults, defined as \>60 years old, self-reporting \>4 METS and with a score of \<2 on the revised cardiac risk index (RCRI)1 we will compare its effectiveness when compared to conventional preoperative evaluation measures (METS determination by standard scoring and Duke Activity Status Index) to SHAPE™ testing.

Primary Outcome

The primary objective for the study is a study enrollment rate of 25% of eligible candidates. Within the parameters of a feasibility study, the following questions will also be addressed: * Physical capacity of clinic to handle the number of participants in the study. * Adequate communication and time frame to efficiently perform abbreviated cardiopulmonary exercise testing in high-volume preoperative testing environment. * Adequate software and hardware to capture and use data obtained from a

Interventions

  • DEVICE Shape II

Study Locations (1)

Connecticut

  • Yale New Haven Hospital - New Haven

Trial Details

FieldValue
Enrollment Target 371 participants
Start Date 2023-05-03
Est. Completion 2026-05-29
Yale University

1,492 total trials

What NCT05743673 shows while recruiting

NCT05743673 is an observational study that tracks outcomes without assigning an intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, above the 292-participant average among 8 other Perioperative/Postoperative Complications trials with a reported enrollment target (27% higher).

The record links to 2 conditions, with Perioperative/Postoperative Complications appearing as the primary indexed condition, and to 1 intervention - of which Shape II is the first listed.

NCT05743673 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT05743673 about?

NCT05743673 is a clinical study titled "SHAPE Test for Preoperative Risk Stratification". Primary Objective Characterizing precise functional capacity in surgical patients is critical for risk stratification and identification of patients at high risk for perioperative complications. The primary objective for the study is to evaluate the feasibility of effective subject recruitment of an...

What is the current status of trial NCT05743673?

This trial is currently recruiting. The enrollment target is 371 participants. The study started on 2023-05-03. Estimated completion is 2026-05-29.

What conditions does trial NCT05743673 study?

This clinical trial studies the following conditions: Perioperative/Postoperative Complications, Aerobic Capacity.

What interventions are being tested in trial NCT05743673?

The interventions under investigation include: Shape II (DEVICE).

Who is sponsoring clinical trial NCT05743673?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05743673 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Perioperative/Postoperative Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05743673's enrollment target sits among peer trials

371 3rd of 8 higher than 6 of 8 other Perioperative/Postoperative Complications trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Perioperative/Postoperative Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05761847 · 371 participants · NA

    Pediatric Medication Therapy Management Trial

  • NCT04801589 · 372 participants · Phase 3

    Goal-Directed Sedation in Mechanically Ventilated Infants and Children

  • NCT04879329 · 372 participants · Phase 2

    A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • NCT05318105 · 372 participants · NA

    Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05743673, the US trial registry maintained by the National Library of Medicine. NCT05743673 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.